536 related articles for article (PubMed ID: 27433079)
1. Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids.
Imamura T; Komatsu S; Ichikawa D; Kawaguchi T; Miyamae M; Okajima W; Ohashi T; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
World J Gastroenterol; 2016 Jul; 22(25):5627-41. PubMed ID: 27433079
[TBL] [Abstract][Full Text] [Related]
2. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy of gastric cancer patients: circulating tumor cells and cell-free nucleic acids.
Tsujiura M; Ichikawa D; Konishi H; Komatsu S; Shiozaki A; Otsuji E
World J Gastroenterol; 2014 Mar; 20(12):3265-86. PubMed ID: 24696609
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer.
Takai E; Yachida S
World J Gastroenterol; 2016 Oct; 22(38):8480-8488. PubMed ID: 27784960
[TBL] [Abstract][Full Text] [Related]
5. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
[TBL] [Abstract][Full Text] [Related]
6. Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers.
Yin CQ; Yuan CH; Qu Z; Guan Q; Chen H; Wang FB
Dis Markers; 2016; 2016():1427849. PubMed ID: 27403030
[TBL] [Abstract][Full Text] [Related]
7. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer: Are "liquid biopsies" ready for prime-time?
Lewis AR; Valle JW; McNamara MG
World J Gastroenterol; 2016 Aug; 22(32):7175-85. PubMed ID: 27621566
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.
Pesta M; Fichtl J; Kulda V; Topolcan O; Treska V
Anticancer Res; 2013 May; 33(5):2239-43. PubMed ID: 23645782
[TBL] [Abstract][Full Text] [Related]
10. Circulating Cell-Free Nucleic Acids as Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer.
Marin AM; Sanchuki HBS; Namur GN; Uno M; Zanette DL; Aoki MN
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189687
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA.
Lee JS; Park SS; Lee YK; Norton JA; Jeffrey SS
Mol Oncol; 2019 Aug; 13(8):1623-1650. PubMed ID: 31243883
[TBL] [Abstract][Full Text] [Related]
13. Circulating micrometastases of esophageal cancer detected by carcinoembryonic antigen mRNA reverse transcriptase-polymerase chain reaction: clinical implications.
Hashimoto T; Kajiyama Y; Tsutsumi-Ishii Y; Nagaoka I; Tsurumaru M
Dis Esophagus; 2008; 21(8):690-6. PubMed ID: 18459988
[TBL] [Abstract][Full Text] [Related]
14. A headlight on liquid biopsies: a challenging tool for breast cancer management.
Massihnia D; Perez A; Bazan V; Bronte G; Castiglia M; Fanale D; Barraco N; Cangemi A; Di Piazza F; Calò V; Rizzo S; Cicero G; Pantuso G; Russo A
Tumour Biol; 2016 Apr; 37(4):4263-73. PubMed ID: 26790442
[TBL] [Abstract][Full Text] [Related]
15. Circulating Tumor Cells, DNA, and mRNA: Potential for Clinical Utility in Patients With Melanoma.
Xu MJ; Dorsey JF; Amaravadi R; Karakousis G; Simone CB; Xu X; Xu W; Carpenter EL; Schuchter L; Kao GD
Oncologist; 2016 Jan; 21(1):84-94. PubMed ID: 26614709
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for early diagnosis of pancreatic cancer.
Jenkinson C; Earl J; Ghaneh P; Halloran C; Carrato A; Greenhalf W; Neoptolemos J; Costello E
Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):305-15. PubMed ID: 25373768
[TBL] [Abstract][Full Text] [Related]
17. Future perspectives of circulating tumor DNA in colorectal cancer.
Nadal C; Winder T; Gerger A; Tougeron D
Tumour Biol; 2017 May; 39(5):1010428317705749. PubMed ID: 28488528
[TBL] [Abstract][Full Text] [Related]
18. Portal-vein blood samples as a new diagnostic entity for pancreatic cancer.
Chapman CG; Waxman I
Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):665-7. PubMed ID: 27077275
[No Abstract] [Full Text] [Related]
19. Circulating Tumor Cells and Cell-Free DNA in Pancreatic Ductal Adenocarcinoma.
Gall TMH; Belete S; Khanderia E; Frampton AE; Jiao LR
Am J Pathol; 2019 Jan; 189(1):71-81. PubMed ID: 30558725
[TBL] [Abstract][Full Text] [Related]
20. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.
Alix-Panabières C; Pantel K
Cancer Discov; 2016 May; 6(5):479-91. PubMed ID: 26969689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]